Merck & Co Inc
NYSE: MRK
$96.51
+$0.20 (+0.2%)
Real Time Data Delayed 15 Min.
MRK Articles
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average components reporting their financial results in the week ahead.
Published:
thinkstockApril 16, 2015: Markets opened lower on Thursday before climbing above the break-even line in the mid-afternoon. Crude oil futures rose to another year-to-date high today and three hot IPOs...
Published:
Last Updated:
thinkstockApril 14, 2015: Markets opened higher on again on Tuesday but all three major indexes slipped below the breakeven line soon thereafter. The S&P 500 and the DJIA pulled back into...
Published:
Last Updated:
The 30-year Treasury Bond yields only about 2.5% and, amazingly, more than half of the 30 Dow Jones Industrial Average stocks are yielding more than that.
Published:
SunTrust Robinson Humphrey analysts expect the pharmaceutical industry to outperform in 2015, driven in part by a solid new product cycle and an attractive five-year growth rate.
Published:
thinkstockMarch 18, 2015: Markets opened lower on Wednesday and bided its time below the break-even line until just after 2 p.m. and the FOMC’s announcement that it would no longer wait patiently...
Published:
Last Updated:
A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to outperform this year.
Published:
With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted from the index next.
Published:
thinkstock February 9, 2015: Markets opened lower on Monday following remarks by Greece’s new president that rattled traders. There was no U.S. economic data out today. Shortly before the closing...
Published:
Last Updated:
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
Published:
Merck reported largely in-line fourth-quarter financial results Wednesday before the U.S. markets opened.
Published:
24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming week.
Published:
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
Published:
Last Updated:
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Published:
One key consideration for the year ahead is Merck's acquisitions of Idenix and Cubist Pharmaceuticals to expand its product offerings
Published:
Last Updated: